Thryvv : ratio page
Zydus Wellness
Financial Ratios
View
Order
Financial Ratios | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Valuation Parameters: | |||||
PE(x) | 35.05 | 31.76 | 30.92 | 105.73 | 52.77 |
PCE(x) | 32.18 | 29.39 | 28.72 | 87.24 | 44.49 |
Price/Book(x) | 1.75 | 1.92 | 1.97 | 2.75 | 2.16 |
Yield(%) | 0.34 | 0.32 | 0.33 | 0.25 | 0.39 |
EV/Net Sales(x) | 4.06 | 4.48 | 4.86 | 6.88 | 5.05 |
EV/Core EBITDA(x) | 29.31 | 29.56 | 27.48 | 36.37 | 26.87 |
EV/EBIT(x) | 33.23 | 32.94 | 29.44 | 65.56 | 34.13 |
EV/CE(x) | 1.66 | 1.87 | 1.73 | 2.32 | 1.79 |
MCap / Sales | 4.02 | 4.37 | 4.75 | 6.72 | 4.23 |
Growth Ratio: | |||||
Net Sales Growth(%) | 3.24 | 12.23 | 7.63 | 5.65 | 109.63 |
Core EBITDA Growth(%) | -5.85 | -3.67 | 0.52 | 6.49 | 48.32 |
EBIT Growth(%) | -7.46 | -7.40 | 69.14 | -24.95 | 30.12 |
PAT Growth(%) | -14.01 | 0.50 | 160.14 | -16.22 | -17.24 |
EPS Growth(%) | -14.01 | 0.54 | 160.15 | -24.08 | -16.21 |
Financial Stability Ratios: | |||||
Total Debt/Equity(x) | 0.06 | 0.06 | 0.08 | 0.12 | 0.44 |
Current Ratio(x) | 1.58 | 1.31 | 1.06 | 1.10 | 1.26 |
Quick Ratio(x) | 0.97 | 0.65 | 0.59 | 0.63 | 0.79 |
Interest Cover(x) | 11.84 | 19.07 | 13.00 | 2.34 | 1.87 |
Total Debt/Mcap(x) | 0.03 | 0.03 | 0.04 | 0.04 | 0.20 |
Operational & Financial Ratios: | |||||
Earnings Per Share (Rs) | 41.97 | 48.81 | 48.54 | 18.66 | 24.58 |
CEPS(Rs) | 45.71 | 52.74 | 52.25 | 22.61 | 29.16 |
DPS(Rs) | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Book NAV/Share(Rs) | 842.37 | 805.44 | 761.28 | 717.87 | 600.18 |
Tax Rate(%) | -2.61 | -6.70 | -0.93 | -5.81 | -16.86 |
Margin Ratios: | |||||
Core EBITDA Margin(%) | 12.36 | 13.95 | 15.91 | 17.11 | 16.63 |
EBIT Margin(%) | 11.40 | 12.70 | 15.40 | 9.74 | 13.53 |
Pre Tax Margin(%) | 10.44 | 12.03 | 14.22 | 5.57 | 6.28 |
PAT Margin (%) | 10.71 | 12.84 | 14.35 | 5.90 | 7.34 |
Cash Profit Margin (%) | 11.67 | 13.87 | 15.45 | 7.15 | 8.71 |
Performance Ratios: | |||||
ROA(%) | 4.57 | 5.48 | 5.52 | 2.16 | 2.62 |
ROE(%) | 5.09 | 6.23 | 6.56 | 2.96 | 4.14 |
ROCE(%) | 5.12 | 5.77 | 6.41 | 3.88 | 5.26 |
Asset Turnover(x) | 0.43 | 0.43 | 0.38 | 0.37 | 0.36 |
Sales/Fixed Asset(x) | 0.50 | 0.49 | 0.44 | 0.41 | 0.40 |
Working Capital/Sales(x) | 5.60 | 11.22 | 45.91 | 26.50 | 12.02 |
Efficiency Ratios: | |||||
Fixed Capital/Sales(x) | 1.99 | 2.04 | 2.27 | 2.41 | 2.47 |
Receivable days | 35.97 | 26.43 | 20.06 | 19.26 | 20.25 |
Inventory Days | 67.75 | 61.84 | 61.58 | 59.57 | 49.65 |
Payable days | 108.40 | 107.90 | 149.46 | 203.71 | 210.15 |